Programme SOM0044 for Parkinson’s Disease
SOM0044 is a small molecule for the treatment of Parkinson’s disease.
AstraZeneca’s Farxiga yields positive results in DAPA-CKD trial
AstraZeneca’s Farxiga is an oral sodium-glucose co-transporter-2 inhibitor. Credit: Bjoertvedt.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
Close
-
Jeeva Informatics Solutions
Jeeva Informatics Solutions (Jeeva) is a seed-stage start-up on a...
About
Jeeva Informatics Solutions (Jeeva) is a seed-stage start-up on a mission to develop artificial intelligence (AI)-driven decentralised clinical trials and optimise patient-focused clinical research.
FollowMake an Enquiry
-
SOM Biotech
SOM Biotech is an Artificial Intelligence AI drug discovery and...
About
SOM Biotech is an Artificial Intelligence AI drug discovery and development company focused on the development of therapies for orphan indications through the proprietary AI-based drug discovery technology.
FollowMake an Enquiry
-
Noble Life Sciences
Noble Life Sciences is a contract research organisation (CRO) offering...
About
Noble Life Sciences is a contract research organisation (CRO) offering preclinical development solutions for drugs, vaccines and medical devices.
FollowMake an Enquiry